Active Ingredient: SODIUM BENZOATE; SODIUM PHENYLACETATE
Proprietary Name: SODIUM PHENYLACETATE AND SODIUM BENZOATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 10%;10% (5GM/50ML;5GM/50ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A208521
Product Number: 001
Approval Date: May 8, 2017
Applicant Holder Full Name: MAIA PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
